Consolidated Statements of Cash Flows - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net loss	[1]	$ (25,224)	$ (34,636)
Adjustments to reconcile net loss to net cash used in operating activities:
(Gain) loss on sale of businesses	[1]	(32,211)	582
Depreciation and amortization	[1]	8,305	11,943
Amortization of debt discounts and deferred financing offering cost	[1]	3,135	2,760
Impairment of intangible asset	[1]	0	3,977
Change in fair value of derivatives liability	[1]	63	0
Change in fair value of Bookings Commitment	[1]	3,727	1,505
Stock-based compensation	[1]	1,049	1,323
Deferred income taxes, net	[1]	(265)	251
Provision for bad debt expense	[1]	121	24
Loss from related party equity method investment	[1]	31,702	4,418
Changes in operating assets and liabilities:
Accounts receivable, net	[1]	4,165	285
Inventories	[1]	(18)	193
Related party receivables, net	[1]	(63)	320
Prepaid expenses and other current assets	[1]	15,640	(1,836)
Accounts payable	[1]	(437)	1,394
Accrued and other current liabilities	[1]	(20,110)	(2,398)
Deferred revenue	[1]	(2,963)	(1,072)
Related party payables, net	[1]	2,934	2,624
Change in operating lease right-of-use assets and liabilities	[1]	(180)	(192)
Other assets and liabilities	[1]	(104)	(629)
Net cash used in operating activities	[1]	(10,734)	(9,164)
Cash flows from investing activities:
Net proceeds from sale of businesses	[1]	46,401	300
Purchases of property and equipment, including internal-use software	[1]	(2,157)	(2,088)
Net cash provided by (used in) investing activities	[1]	44,244	(1,788)
Cash flows from financing activities:
Repayments of insurance promissory note	[1]	(238)	0
Tax payments related to stock issued, net of stock withheld, for vested equity awards	[1]	(739)	(267)
Net cash used in financing activities	[1]	(977)	(267)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	[1]	(11)	(10)
Net increase (decrease) in cash, cash equivalents and restricted cash	[1]	32,522	(11,229)
Cash, cash equivalents and restricted cash, beginning of period	[1],[2]	6,379	19,441
Cash, cash equivalents and restricted cash, end of period	[1],[2]	38,901	8,212
Supplemental disclosure of cash flow information:
Interest paid		2,944	2,943
Noncash investing and financing activities:
Purchases of property and equipment including internal use software		$ 102	$ 91

[1] The statements for the six months ended June 30, 2020 and 2019 include the Connected Care Business (see Note 4).

[2] Cash and cash equivalents included restricted cash of $1,136 and $1,375 at December 31, 2019 and June 30, 2020, respectively, and $1,136 and $1,136 at December 31, 2018 and June 30, 2019, respectively. Restricted cash is included in other assets and consists of funds that are contractually restricted as to usage or withdrawal related to the Company's security deposits in the form of standby letters of credit for leased facilities and funds held in an escrow account related to the sale of the Connected Care Business (see Note 4). No amounts have been drawn upon the letters of credit as of June 30, 2020.